It reflects the extreme concern of the professional community about the risk of interruptions in the supply of medicines to the population of the Russian Federation in connection with the expected introduction of the Trace & Track system for medicines as of July 01, 2020.
Earlier this month the industry position on the implementation of T&T project in Russia was submitted by 11 major industry Associations of drug manufacturers, distributors, pharmacy organizations and the patient society (ARFP, AIPM, SPFO, ROSMEDPROM, National Pharmaceutical Chamber Union, Inpharma, APF , RAAS, SOYUZPHARMA, Association of Independent Pharmacies, All-Russian Union of Public Patient Associations) to the President of Russian Federation V.V. Putin to support the extension of transition period for the T&T implementation in Russia at least by 1.01.2021. Letters also were directed to the State Duma, to the Government of Russian Federation and Federal executive bodies.